2007
DOI: 10.1021/jm061131z
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α

Abstract: The synthesis and structure-activity relationship of a series of indole inhibitors of cytosolic phospholipase A2alpha (cPLA2alpha, type IVA phospholipase) are described. Inhibitors of cPLA2alpha are predicted to be efficacious in treating asthma as well as the signs and symptoms of osteoarthritis, rheumatoid arthritis, and pain. The introduction of a benzyl sulfonamide substituent at C2 was found to impart improved potency of these inhibitors, and the SAR of these sulfonamide analogues is disclosed. Compound 1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
96
0
2

Year Published

2008
2008
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 75 publications
(99 citation statements)
references
References 60 publications
1
96
0
2
Order By: Relevance
“…A previous study on cPLA2 alpha-deficient mice [10] led to the development of certain compounds and their examination in pharmacological studies [31][32][33][34]. However, it remained unclear whether the phenotype of cPLA2 alpha-deficient mice should be attributed to the reduction in eicosanoid production such as LTB 4 or PGE 2 [10].…”
Section: Discussionmentioning
confidence: 99%
“…A previous study on cPLA2 alpha-deficient mice [10] led to the development of certain compounds and their examination in pharmacological studies [31][32][33][34]. However, it remained unclear whether the phenotype of cPLA2 alpha-deficient mice should be attributed to the reduction in eicosanoid production such as LTB 4 or PGE 2 [10].…”
Section: Discussionmentioning
confidence: 99%
“…During the course of the SAR study which eventually led to the compound Ecopladib, a C-N coupling with JohnPhos was employed (Scheme 41). [198] It is notable that the presence of multiple acidic hydrogens in the aryl halide substrate did not interfere with the coupling which had previously been successfully applied in the transformation of simpler members of the series. [199] Augustyns at the University of Antwerp utilized the coupling of a primary amine and bromobenzene during the course of work on the synthesis of selective dipeptidyl peptidase II inhibitors which have potential for the treatment of a range of diseases (Scheme 42).…”
Section: Applications In Pharmaceutical Synthesismentioning
confidence: 98%
“…Im Verlauf der Struktur-Aktivitäts-Studie, die schließlich zu Ecopladib führte, wurde eine C-N-Kupplung mit JohnPhos eingesetzt (Schema 41). [198] Es ist bemerkenswert, dass mehrere acide Protonen am ArylhalogenidSubstrat die Kupplung nicht beeinträchtigten. [199] Augustyns [201] Wegen der kurzen Halbwertszeit von 18 F (t 1/2 = 109.6 min) müssen die Reaktionen schnell ablaufen.…”
Section: Angewandte Chemieunclassified